Graphene-Based Transistor Detects Bacteria in Microdroplets
By LabMedica International staff writers Posted on 01 Jul 2019 |

Image: An illustration of a bacterial detection by the G-FET device (Photo courtesy of Osaka University).
A team of Japanese researchers developed a graphene-based field-effect transistor and used it to detect the gastric cancer pathogen Helicobacter pylori in fluid microdroplets.
Graphene is an allotrope of carbon in the form of a two-dimensional hexagonal lattice in which one atom forms each vertex. It is the basic structural element of other allotropes, including graphite, charcoal, carbon nanotubes, and fullerenes. At one atom thick, graphene is the thinnest material known to man and is also one of the strongest, being approximately 200 times stronger than steel. It is an excellent conductor of heat and electricity and has interesting light absorption properties.
Investigators at Osaka University (Japan) coated micro sized sheets of graphene with specific antibodies to create highly sensitive graphene-based field effect transistors (GFETs) for use as biosensors and chemical sensors. Due to the two-dimensional structure of graphene, along with its physical properties, GFETs offer increased sensitivity, and reduced instances of false positives responses in sensing applications.
To use a GFET to detect bacteria, the investigators faced a peculiar physical limitation. The measurable range from the graphene surface is highly restricted by Debye screening, with characteristic length less than one nanometer at physiological ionic strength. This screening effect prevented the graphene sheet from being affected by binding of bacteria to the antibody coating.
To overcome the Debye screening limitation, the investigators introduced a way to monitor chemical reactions generated by the bacteria in the presence of reagents added by microfluidics to a droplet of liquid. The low molecular weight chemicals produced in the reactions were able to penetrate the Debye screen and reach the graphene surface. Electrical signals built up on the graphene surface due to these reactions were used to calculate the number of bacteria in the droplet.
The investigators demonstrated that they could achieve quantitative measurements of a target based on the site-binding model and real-time measurement of enzyme kinetics in femtoliter (10 x -15 liter or a cubic microliter) microdroplets.
The combination of a G-FET and microfluidics, called by the investigators a “lab-on-a-graphene-FET”, detected the enzyme urease with high sensitivity in the zeptomole (one 10 x -21th part of a mole, or about 600 molecules) range in 100 millimolar sodium phosphate buffer. Furthermore, the lab-on-a-graphene-FET detected the gastric cancer pathogen Helicobacter pylori captured at a distance greater than the Debye screening length from the G-FET.
"Our biosensor is essentially a mini laboratory on a graphene FET. This sensor demonstrates how two-dimensional materials such as graphene are getting closer to being applied in practical medical and healthcare applications," said first author Dr. Takao Ono, an assistant professor in the institute of scientific and industrial research at Osaka University.
The use of the G-FET device to detect H. pylori was described in the June 12, 2019, issue of the journal ACS Nano Letters.
Related Links:
Osaka University
Graphene is an allotrope of carbon in the form of a two-dimensional hexagonal lattice in which one atom forms each vertex. It is the basic structural element of other allotropes, including graphite, charcoal, carbon nanotubes, and fullerenes. At one atom thick, graphene is the thinnest material known to man and is also one of the strongest, being approximately 200 times stronger than steel. It is an excellent conductor of heat and electricity and has interesting light absorption properties.
Investigators at Osaka University (Japan) coated micro sized sheets of graphene with specific antibodies to create highly sensitive graphene-based field effect transistors (GFETs) for use as biosensors and chemical sensors. Due to the two-dimensional structure of graphene, along with its physical properties, GFETs offer increased sensitivity, and reduced instances of false positives responses in sensing applications.
To use a GFET to detect bacteria, the investigators faced a peculiar physical limitation. The measurable range from the graphene surface is highly restricted by Debye screening, with characteristic length less than one nanometer at physiological ionic strength. This screening effect prevented the graphene sheet from being affected by binding of bacteria to the antibody coating.
To overcome the Debye screening limitation, the investigators introduced a way to monitor chemical reactions generated by the bacteria in the presence of reagents added by microfluidics to a droplet of liquid. The low molecular weight chemicals produced in the reactions were able to penetrate the Debye screen and reach the graphene surface. Electrical signals built up on the graphene surface due to these reactions were used to calculate the number of bacteria in the droplet.
The investigators demonstrated that they could achieve quantitative measurements of a target based on the site-binding model and real-time measurement of enzyme kinetics in femtoliter (10 x -15 liter or a cubic microliter) microdroplets.
The combination of a G-FET and microfluidics, called by the investigators a “lab-on-a-graphene-FET”, detected the enzyme urease with high sensitivity in the zeptomole (one 10 x -21th part of a mole, or about 600 molecules) range in 100 millimolar sodium phosphate buffer. Furthermore, the lab-on-a-graphene-FET detected the gastric cancer pathogen Helicobacter pylori captured at a distance greater than the Debye screening length from the G-FET.
"Our biosensor is essentially a mini laboratory on a graphene FET. This sensor demonstrates how two-dimensional materials such as graphene are getting closer to being applied in practical medical and healthcare applications," said first author Dr. Takao Ono, an assistant professor in the institute of scientific and industrial research at Osaka University.
The use of the G-FET device to detect H. pylori was described in the June 12, 2019, issue of the journal ACS Nano Letters.
Related Links:
Osaka University
Latest Technology News
- Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
- Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
- Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
- Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
- Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
- Smartphones Could Diagnose Diseases Using Infrared Scans
- Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
- 3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
- POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
- Study Explores Impact of POC Testing on Future of Diagnostics
- Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
- Nanotechnology For Cervical Cancer Diagnosis Could Replace Invasive Pap Smears
- Lab-On-Chip Platform to Expedite Cancer Diagnoses
- Biosensing Platform Simultaneously Detects Vitamin C and SARS-CoV-2
- New Lens Method Analyzes Tears for Early Disease Detection
- FET-Based Sensors Pave Way for Portable Diagnostic Devices Capable of Detecting Multiple Diseases
Channels
Clinical Chemistry
view channel
AI-Powered Blood Test Accurately Detects Ovarian Cancer
Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more
Automated Decentralized cfDNA NGS Assay Identifies Alterations in Advanced Solid Tumors
Current circulating cell-free DNA (cfDNA) assays are typically centralized, requiring specialized handling and transportation of samples. Introducing a flexible, decentralized sequencing system at the... Read moreMass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication
Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more
First Comprehensive Syphilis Test to Definitively Diagnose Active Infection In 10 Minutes
In the United States, syphilis cases have surged by nearly 80% from 2018 to 2023, with 209,253 cases recorded in the most recent year of data. Syphilis, which can be transmitted sexually or from mother... Read moreHematology
view channel
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read more
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV
Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, led to 1.25 million deaths in 2023, with 13% of those occurring in people living with HIV. The current primary diagnostic method for... Read more
New Test Diagnoses Bacterial Meningitis Quickly and Accurately
Bacterial meningitis is a potentially fatal condition, with one in six patients dying and half of the survivors experiencing lasting symptoms. Therefore, rapid diagnosis and treatment are critical.... Read morePathology
view channel
Groundbreaking Chest Pain Triage Algorithm to Transform Cardiac Care
Cardiovascular disease is responsible for a third of all deaths worldwide, and chest pain is the second most common reason for emergency department (ED) visits. With EDs often being some of the busiest... Read more
AI-Based Liquid Biopsy Approach to Revolutionize Brain Cancer Detection
Detecting brain cancers remains extremely challenging, with many patients only receiving a diagnosis at later stages after symptoms like headaches, seizures, or cognitive issues appear. Late-stage diagnoses... Read moreTechnology
view channel
Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more